AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute pain, today …
In a research report issued today, Roth Capital analyst Michael Higgins reiterated a Buy rating on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) while raising the …
In a research report released Tuesday, Roth Capital analyst Michael Higgins reiterated a Buy rating on shares of AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), while raising …
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) announced that the European Commission (EC) has approved Zalviso™ (15 micrograms sufentanil sublingual tablets) for the management of acute moderate-to-severe …
AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough …
In a research report released Monday, H.C.
Roth Capital’s healthcare analyst Michael Higgins weighed in with a few insights on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX), after the company announced that it held an informal meeting …
MannKind Corporation (NASDAQ:MNKD) fell 10.07% in pre-market trading to $3.
After repeat attempts to convince the U.S.
